+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

From
From
From
From
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • February 2026
  • Global
Strategic Intelligence: Cell and Gene Therapy Investment Trends - Product Thumbnail Image

Strategic Intelligence: Cell and Gene Therapy Investment Trends

  • Report
  • December 2025
  • 36 Pages
  • Global
From
From
Cell Gene Therapy CDMO Market - Product Thumbnail Image

Cell Gene Therapy CDMO Market

  • Report
  • October 2025
  • 80 Pages
  • Global
From
Bioreactors Market Overview, 2025-30 - Product Thumbnail Image

Bioreactors Market Overview, 2025-30

  • Report
  • August 2025
  • 115 Pages
  • Global
From
Cell Counting Market Outlook, 2030 - Product Thumbnail Image

Cell Counting Market Outlook, 2030

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Cell Counting Market Overview, 2025-30 - Product Thumbnail Image

Cell Counting Market Overview, 2025-30

  • Report
  • June 2025
  • 105 Pages
  • Global
From
From
From
From
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 - Product Thumbnail Image

Middle East Cell and Gene Therapy CDMO Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Middle East
From
From
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more